Nephros, Inc. (NEPH)
4.08
+0.17
(+4.35%)
USD |
NASDAQ |
Mar 02, 16:00
4.12
+0.04
(+0.98%)
After-Hours: 20:00
Nephros EPS Diluted (Quarterly) : 0.0305 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Apyx Medical Corp. | -0.0487 |
| Cerus Corp. | -0.0001 |
| Owlet, Inc. | 0.1338 |
| Abbott Laboratories | 1.030 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.337M |
| Revenue (Quarterly) | 4.764M |
| Total Expenses (Quarterly) | 4.427M |
| Enterprise Value | 39.34M |
| Gross Profit Margin (Quarterly) | 60.47% |
| Profit Margin (Quarterly) | 7.07% |
| Earnings Yield | 3.38% |
| Operating Earnings Yield | 3.29% |
| Normalized Earnings Yield | 3.385 |